California MD's DEA Registration Revoked Without a Hearing
Published Date: 9/21/2026
Notice
Summary
Dr. John Ramsay Walters from California lost his DEA registration to handle controlled substances because he no longer has the legal authority to prescribe them in his state. He didn’t ask for a hearing to challenge this, so the DEA officially revoked his registration as of May 31, 2026. This means he can’t legally prescribe or dispense controlled drugs anymore, affecting his medical practice and patients.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
DEA Registration Revoked for Dr. Walters
The DEA revoked John Ramsay Walters, M.D.'s Certificate of Registration No. AW8146602, effective October 21, 2026. His DEA registration had expired on May 31, 2026, and he surrendered his California medical license effective December 31, 2025, so he cannot legally prescribe or dispense controlled substances in California anymore.
Pending Registration Applications Denied
The DEA denied any pending applications by John Ramsay Walters, M.D., to renew or modify Certificate of Registration No. AW8146602 and denied any other pending application for additional registration in California. That denial is part of the same Order that is effective October 21, 2026.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-19231, Schedules of Controlled Substances: Placement of Diphenidine in Schedule I
Starting October 21, 2026, diphenidine and its related forms will be officially listed as Schedule I drugs, meaning they’re considered highly controlled with no accepted medical use. This change affects anyone who makes, sells, studies, or even possesses diphenidine, bringing strict rules and serious penalties. The move helps the U.S. follow international drug laws and keep communities safer.
2026-19232, Esther Villanueva Valdes, M.D.; Decision and Order
Dr. Esther Villanueva Valdes from Puerto Rico lost her DEA registration because she’s no longer allowed to handle controlled substances and was excluded from federal health programs like Medicare and Medicaid. She didn’t ask for a hearing, so the decision to revoke her registration is final. This means she can’t legally prescribe or manage controlled drugs anymore, effective immediately.
2026-18604, Joseph John Stubbers III, D.O.; Decision and Order
Dr. Joseph John Stubbers III from Ohio lost his DEA registration to handle controlled substances because he no longer has the legal authority to prescribe them in Ohio. He didn’t ask for a hearing to challenge this, so the DEA officially revoked his registration as of February 28, 2026. This means he can’t legally prescribe or manage controlled drugs anymore, impacting his medical practice and patients.
2026-18597, Craig Cohen, DPM; Decision and Order
Dr. Craig Cohen from Ohio lost his DEA registration because he no longer has permission to handle controlled substances in his state. He didn’t respond to the DEA’s attempts to contact him or request a hearing, so the agency revoked his certificate. This means he can’t legally prescribe or manage controlled drugs anymore, effective immediately.
Previous / Next Documents
Previous: 2026-19229, Notice of Formal Determination on Records Release
The Civil Rights Cold Case Records Review Board decided which old civil rights case files can be released and which need to be postponed. They approved 3 new postponements out of 22 requests, keeping some records under wraps a bit longer. This update affects anyone following these cases and happens right on schedule, with no extra costs involved.
Next: 2026-19232, Esther Villanueva Valdes, M.D.; Decision and Order
Dr. Esther Villanueva Valdes from Puerto Rico lost her DEA registration because she’s no longer allowed to handle controlled substances and was excluded from federal health programs like Medicare and Medicaid. She didn’t ask for a hearing, so the decision to revoke her registration is final. This means she can’t legally prescribe or manage controlled drugs anymore, effective immediately.